Delgado CR, Rembao BD, Ruiz-Godoy RLM, Ramírez PE, Meneses GA

Language: English
References: 22
Page: 115-119
PDF size: 395.56 Kb.

ABSTRACT

Backgrond: Inflammatory stimuli have been found to exert little effect on COX-1 expression, but are well-known for leading to a rapid rise in COX-2 mRNA, suggesting that COX-2 plays a role in the inflammation process. COX-2 may also play an important role in neurodegeneration,and in particular in citotoxic neuron death.
Objective: To analyze in brain tissue from autopsies of 13 patients with cancer –five of them treated with chemotherapy and the other eight without chemotherapy– expression of cyclooxygenase-2 (COX-2), mRNA and interleukin-1β.
Material and methods: In brain tissue of 13 patients with different kinds of primary malignant tumors the interleukin-1β and cyclooxygenase-2 expression was analyzed in autopsy, five patients were treated with chemotherapy and eight without chemotherapy. It was realized by real time RT-PCR of total RNA of cerebral cortex and white materia tissue preserved in -80°C, and it was used, primers and fluorophore-labeled TaqMan probes targeting human COX-2 and IL-1β.
Results: Brain tissue from patients with chemotherapy had significantly higher interleukin-1β and cyclooxygenase-2 expression in frontal cortex and hippocampus.
Conclusion: These findings suggest that exposure to cytotoxic drugs is associated with COX-2 gene induction by interleukin-1β, neuronal dysfunction that could precede the neurologic complications of chemotherapy treatment.

REFERENCES

1. Armstrong T, Gilbert MR. Central nervous system toxicity from cancer treatment. Curr Oncol Resp 2004;6:11-19.

2. Verstappen CC, Heimans JJ, Hooekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003;63:1549-1563.

3. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-12872.

4. O’Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992;89:4888-4892.

5. Cao C, Matsumura K, Yamagata K, Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res 1995;697:187-196.

6. Tamura M, Sebastián S, Yang S, Gurates B, et al. Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab 2002;87:3263-3273.

7. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000;293:417-425.

8. Carson JL, Reed W, Lucier T, Brighton L, et al. Axonemal dynein expression in human fetal tracheal epithelium. Amer J Physiol Lung Cell Mol Physiol 2002;282:L421-430.

9. Orbach D, Brisse H, Doz F. Neurotoxicity of cancer chemotherapy. Semin Neurol 2004;24:419-426.

10. Reddy ST, Wite KK. Neurologic complications of chemotherapy for children with cancer. Curr Neurol Neurosci Rep 2003;3:137-142.

11. Lukiw WJ, Bazan NG. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 1997;50:937-945.

12. Liu B, Hong JS. Role of microglia in inflammation mediated neurodegenerative disease: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003;304:1-7.

13. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 1988;38:1285-1291.

14. Raine CS. Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 1994;53:328-337.

15. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003;54:469-487.

16. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001;2:907-916.

17. Faber JL. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 1994;102:17-24.

18. Wang T, Qin L, Liu B, Liu Y, et al. Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem 2004;88:939-947.

19. Sotelo J, Guevara P, Pineda B, Díaz C. Interstitial quinacrine activates a distinctive immune response effective for tumor immunotherapy. Surgery 2004;136:700-7.

20. Sotelo J, Guevara P, Reyes S, Arrieta O. Interstitial quinacrine for elimination of abnormal tissue; therapy of experimental glioma. Surgery 2000;128:439-446.